ALGNHealthcare · Medical Instruments & SuppliesThe 17 Wall Street analysts covering Align Technology, Inc. hold a median 12-month price target of $209 — +36.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 84 of 100 as at 8 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Align Technology, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (96): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Momentum (53): The shares have been drifting down relative to others.
Size (15): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ALGN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +36.7% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 23 July 2026 | UBS | Maintains | Neutral | $186 → $189 |
| 9 July 2026 | BMO Capital | Initiates | Outperform | $209 |
| 9 July 2026 | BMO Capital | Initiates | Outperform | — |
| 30 Apr 2026 | Evercore ISI Group | Maintains | Outperform | — |
| 30 Apr 2026 | Mizuho | Maintains | Outperform | — |
| 24 Apr 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 21 Apr 2026 | Piper Sandler | Maintains | Overweight | — |
| 15 Apr 2026 | Citigroup | Initiates | Buy | — |
| 17 Mar 2026 | Barclays | Upgrade | Overweight | — |
| 26 Feb 2026 | Barclays | Maintains | Equal-Weight | — |
| 9 Feb 2026 | HSBC | Upgrade | Buy | — |
| 5 Feb 2026 | Evercore ISI Group | Maintains | Outperform | — |
| 5 Feb 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 5 Feb 2026 | Piper Sandler | Maintains | Overweight | — |
| 5 Feb 2026 | Stifel | Maintains | Buy | — |
| 5 Feb 2026 | UBS | Maintains | Neutral | — |
| 5 Feb 2026 | Wells Fargo | Maintains | Overweight | — |
| 20 Jan 2026 | Mizuho | Maintains | Outperform | — |
| 9 Dec 2025 | Barclays | Initiates | Equal-Weight | — |
| 30 Oct 2025 | Evercore ISI Group | Maintains | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ALGN appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 9 Sept 2026, Align Technology, Inc. returned +12.5% against +18.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 28% of US stocks
Cheaper than 45% of US stocks
Cheaper than 37% of US stocks
Cheaper than 34% of US stocks
Higher than 37% of US stocks
Higher than 24% of US stocks
Higher than 84% of US stocks
Higher than 77% of US stocks
Higher than 70% of US stocks
Higher than 64% of US stocks
Higher than 86% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Align Technology, Inc. has a market value of $10.9B and an enterprise value of $9.9B.
Revenue in the twelve months to 30 June 2026: $4.1B. The latest quarter grew 4.3% year on year.
Net income over the same four quarters: $413.6M, a 10.0% net margin.
Diluted earnings per share, trailing twelve months: $5.75.
Free cash flow in the twelve months to 30 June 2026: $633.6M.
Align Technology, Inc. spent $266.9M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 26.4×; forward P/E: 12.1× — the forward figure prices analyst consensus estimates, not reported earnings.
Align Technology, Inc. employs 20,435 people — $203K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Align Technology, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Align Technology announced it is scheduled to speak at an upcoming financial conference, with the presentation to be webcast live via the Investor Relations section of its website.
Why it matters — ALGN watchers can follow the webcast to hear management discuss the company's business at a financial conference.
Align Technology announced that its Board of Directors has appointed Quentin Blackford, President and CEO of iRhythm Technologies, as a director effective immediately.
Why it matters — ALGN watchers would care because the company is adding an experienced medical device executive to its board of directors.
Align Technology reported earnings 30 days ago, and the article notes that its stock has fallen 8.4% since that report. The piece poses the question of what may come next for the company following this decline.
Why it matters — ALGN watchers would care because the article highlights the stock's decline since the last earnings release, prompting questions about the company's near-term outlook.
Align Technology faces a $37.5 million U.K. VAT liability, new 20% VAT charges, and a pending appeal, adding fresh earnings uncertainty amid currency and product-mix pressures, according to Zacks Investment Research.
Why it matters — A ALGN watcher would care because the U.K. VAT ruling introduces new financial obligations and appeal-related uncertainty that could weigh on the company's 2026 earnings outlook.
Zacks Investment Research examines Align Technology's investment case, noting record Clear Aligner growth and global adoption as supporting the bull case, while flagging demand softness and scanner pricing pressure as cautionary factors for investors.
Why it matters — ALGN watchers would care because this analysis weighs the company's strong Clear Aligner momentum against ongoing demand and pricing headwinds that could influence its near-term outlook.
The 17 Wall Street analysts covering Align Technology, Inc. have a median 12-month price target of $209, with estimates ranging from $170 to $240. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 17 analysts covering Align Technology, Inc., 11 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Align Technology, Inc. 84 out of 100 across roughly 4,600 US stocks as at 8 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 8 Sept 2026, Align Technology, Inc. ranks 84 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (96 of 100).
No one can know that. What the data says: the median 12-month target from 17 analysts implies +36.7% from the last close, and Ticker Nerd's factor model ranks Align Technology, Inc. 84 out of 100 as at 8 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Align Technology, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALGN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $170 to $240 over the next 12 months.
Align Technology, Inc. returned +12.5% over the 12 months to 9 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Align Technology Inc. is a medical device company focused on digital orthodontics and restorative dentistry.
The most recent item we track (Business Wire, 8 Sept 2026): "Align Technology to Speak at Upcoming Financial Conference". Align Technology announced it is scheduled to speak at an upcoming financial conference, with the presentation to be webcast live via the Investor Relations section of its website.
Align Technology Inc. is a medical device company focused on digital orthodontics and restorative dentistry. The company develops and markets the Invisalign clear aligner system, Vivera retainers, and a range of intraoral scanning and digital treatment-planning tools used by dental professionals. Its iTero scanners and related services support precise imaging, workflow efficiency, and chairside communication in orthodontic and general dentistry practices. Align Technology also offers exocad CAD/CAM software, extending its presence across dental design and fabrication workflows. The company serves dentists, orthodontists, and dental laboratories in markets around the world, with products designed to support treatment planning, patient monitoring, and restorative procedures. Align Technology plays a central role in the shift from traditional braces and analog dental processes to connected, software-enabled oral healthcare solutions.
CEO Mr. Joseph M. Hogan · 20,435 employees · United States · https://www.aligntech.com
